Read UMR's July 13 Statement on NIH Funding in House Labor-HHS Appropriations Bill
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
NIH's Role In Sustaining the U.S. Economy | 2023 Update Now Available
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

“Public Health on Call” Podcast: The Value of Masks & Testing in Schools

“Public Health on Call” Podcast: The Value of Masks & Testing in Schools

In this episode, Dr. Josh Sharfstein talks with researchers who break down two papers in the news. Dr. Nikolas Wada talks about a study led by researchers in Bangladesh and the U.S. which tested whether masks really help to reduce the spread of COVID-19. Dr. Kate Grabowski discusses a Lancet paper from the U.K. about … Continued

Better Protection for Transplant Recipients

That question—whether the vaccine would protect transplant patients like Keefer and others with compromised immune systems—set Dorry Segev, director of the Epidemiology Research Group in Organ Transplantation at Johns Hopkins, onto a path of scientific inquiry that has produced more than three dozen papers since February on COVID-19 vaccination in immunocompromised people and resulted in … Continued

New demographic data tools tell the story of COVID-19’s impact in the U.S.

The Johns Hopkins Coronavirus Resource Center today released demographic data and new tools to show the impact COVID-19 has had across the United States as measured by age, race and ethnicity, and gender and sex. The 7,700 data points collected and processed each month from 55 U.S. states and jurisdictions provide one of the most detailed … Continued

New global dashboard sheds light on reasons behind COVID vaccine hesitancy, refusal

Interactive tool created with survey data collected from more than 12 million people from 115 countries and analyzed by the Johns Hopkins Center for Communication Programs

Johns Hopkins Coronavirus Team Details Lack of Daily Data on COVID-19

The Johns Hopkins Coronavirus Resource Center today published a new graphic visualization and analysis detailing the troubling trend of U.S. states eliminating daily reporting of COVID-19 data. According to Coronavirus Resource Center experts, the reduction in daily reporting on cases, hospitalizations, deaths, and other vital data is taking place at a time when more public data … Continued

“Public Health on Call” Podcast: How Worried Should the Vaccinated be About Delta?

With so much news about the Delta variant and calls for many vaccinated people to mask up again, Gigi Gronvall of the Johns Hopkins Center for Health Security talks with Stephanie Desmon about what we know right now about breakthrough COVID-19 infections and how worried the vaccinated should be about getting sick from COVID-19.

Decoding Delta: How Viruses Mutate and What Can Be Done About It

Johns Hopkins University virologist Andrew Pekosz discusses what we know so far about the delta variant of the coronavirus and what it means for our understanding of SARS-CoV-2 overall.

“Public Health on Call” Podcast: COVID-19 Vaccine Boosters, FDA Approval, New Vaccines, and More

Will we need COVID-19 booster shots and, if so, when? Where is the FDA in its approval process of the vaccines currently under emergency use authorization? What goes into this process? Why, if the current vaccines are so good, are companies still trying to make new ones? Johns Hopkins’ Dr. Anna Durbin returns to the … Continued

“Public Health on Call” Podcast: The consequences of COVID

Three researchers break down three papers looking at what happens to patients with COVID over the longer term. Dr. Lauren Peetluck, an epidemiologist at Vanderbilt University, talks about the risks of long-term complications of COVID. Dr. Heather McKay, an epidemiologist at Johns Hopkins, talks about the risks of negative neurological and psychiatric outcomes of patients … Continued

Drop in convalescent plasma use at U.S. hospitals linked to higher COVID-19 mortality rate

A new study from researchers at Johns Hopkins Bloomberg School of Public Health and colleagues suggests that a slowdown in the use of convalescent plasma to treat hospitalized COVID-19 patients led to higher COVID-19 mortality during a critical surge in cases in the winter.